©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 116100
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.116100
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.116100
| Outcome | STARR | VR | Ref. |
| Symptomatic recurrence (5-10 years) | 20%-40% (up to about 40% at 10 years) | < 10% (about 8%-10% at 10 years) | Schiano di Visconte[5]; Mandovra et al[43]; Barra et al[44] |
| Symptom improvement at 12 months | 70%-90% (approximately 85% in one series) | 70%-90% (durable relief) | Schiano di Visconte[5]; Mandovra et al[43]; Mäkelä-Kaikkonen et al[45] |
| Anatomical recurrence | Approximately 20%-38% (rectocele/intussusception) | < 5%-8% | Mandovra et al[43]; Barra et al[44] |
| Surgical re-intervention rate | Up to about 20%-25% | < 10% | Mäkelä-Kaikkonen et al[45]; Gagliardi et al[46] |
| Quality-of-life improvement | Improves initially but declines at long-term follow-up | Stable/sustained improvement | Mandovra et al[43]; Mäkelä-Kaikkonen et al[45] |
| Procedure-specific complications | Urgency, pain/tenesmus (approximately 20%); rare anastomotic dehiscence or fistula | Mesh-related complications about 1%-2% (erosion about 0.9%); rare mesh detachment | Hess et al[47]; Ripamonti et al[18] |
| Patient satisfaction | About 70%-75% overall long-term satisfaction; about 20%-35% “very satisfied” at 10 years | About 70%-85% “high satisfaction” at 2 years | Mandovra et al[43]; Mäkelä-Kaikkonen et al[45]; Schiano di Visconte et al[6] |
| Mean operative time | Approximately 40 minutes | Approximately 115 minutes | Mandovra et al[43]; Mandovra et al[48] |
| Hospital stay (days) | Approximately 2.1 days | Approximately 3.3 days | Mandovra et al[43]; Mandovra et al[48] |
Table 2 Stratified treatment recommendations by phenotype
| Phenotype | Key clinical features | Diagnostic findings (defecography/HRAM) | Recommended primary intervention | Rationale/clinical notes |
| Isolated structural ODS | Single anatomical defect (large rectocele or low-grade internal intussusception); preserved sphincter function and no major dyssynergia | Defecography: Solitary rectocele or low-grade internal prolapse without multi-compartment involvement; HRAM: Normal relaxation pattern and adequate rectal propulsive pressure | STARR or targeted local repair (e.g., site-specific rectocele repair) | Minimally invasive and directly addresses the mechanical obstruction; high symptom relief and satisfaction (> 80%) in appropriately selected “simple” ODS when continence and coordination are preserved |
| Complex structural ODS (multi-compartment) | Combined defects (e.g., rectocele with intussusception and/or enterocele and/or perineal descent) or high-grade internal prolapse approaching external prolapse | Defecography: Multi-compartment pelvic organ prolapse (anterior, apical, and posterior compartments) or high-grade internal prolapse; HRAM: Generally preserved coordination but anatomical obstruction predominates | Ventral rectopexy (LVMR/RVMR) and/or adjunct pelvic repairs; in selected women with multi-organ pelvic support defects, POPS with or without concomitant transanal repair | Provides comprehensive anatomical correction and pelvic support with long-term recurrence < 10%; VR addresses combined rectocele with intussusception and reduces perineal descent; in multi-compartment female prolapse, POPS offers comparable ODS relief while avoiding extensive sacral dissection, preserving sexual function, and remaining fully compatible with transanal procedures |
| Functional ODS with dyssynergia (types I-III FDD) | Outlet obstruction without structural lesion; paradoxical contraction or incomplete relaxation of the pelvic floor during attempted defecation | Defecography: Minimal or absent mechanical obstruction; HRAM: Types I-III coordination failure (paradoxical contraction, inadequate relaxation, or mixed pattern); Balloon expulsion test: Prolonged or failed | First-line: Pelvic-floor biofeedback and retraining; Second-line adjunct in refractory cases: Targeted botulinum toxin injection to puborectalis and/or internal anal sphincter | Corrects functional dyssynergia and avoids unnecessary surgery; success in up to 70% of patients; adjunctive botulinum toxin can transiently reduce hypertonicity, facilitate pelvic floor relaxation, and enhance the effectiveness of biofeedback in selected refractory cases within a multimodal rehabilitation strategy |
| Rectal inertia (type IV FDD) | Severe outlet obstruction with marked straining, sense of incomplete evacuation, often associated with slow-transit constipation; anal relaxation preserved but expulsive force inadequate | Defecography: Little or no fixed mechanical obstruction despite persistent incomplete emptying; HRAM: Type IV pattern with normal or adequate anal relaxation but markedly reduced rectal propulsive pressure (< 40 mmHg); Balloon expulsion: Markedly prolonged or failed | Motility-targeted therapies (intensified conservative measures, laxative optimization, and neuromodulation); in carefully selected severe cases with combined colonic/rectal inertia, consideration of resectional procedures; avoid suspensive operations such as STARR or ventral mesh rectopexy | Represents a distinct rectal inertia phenotype in which the primary defect is propulsion failure rather than obstruction; suspensive procedures may “anchor” a non-propulsive rectum and worsen symptoms without correcting motility; management should prioritize restoration of motility (including neuromodulation) and reserve resectional surgery for selected refractory patients, rather than applying standard suspensive ODS operations |
| Mixed ODS (structural with dyssynergia) | Coexistence of structural lesion (e.g., rectocele or internal intussusception) and functional defecatory disorder (paradoxical pelvic floor contraction) | Defecography: Demonstrable rectocele and/or internal prolapse; HRAM: Dyssynergic pattern (types I-III) | Stepwise multimodal therapy: Initial pelvic-floor physical therapy and biofeedback to correct dyssynergia, followed by anatomical correction (STARR, VR, or local repair as indicated by the dominant mechanical defect) | Surgery alone may only partially relieve symptoms when dyssynergia is ignored; treating the functional deficit first, then addressing the anatomical obstruction, reduces the risk of persistent ODS, postoperative urgency, and recurrence; staged, phenotype-guided management improves overall outcomes |
| ODS with compromised continence | ODS associated with weak sphincter, obstetric injury, or low anal pressures | HRAM: Low resting and/or squeeze pressures; Endoanal ultrasound or MRI may show sphincter defects; Clinical history of urge or passive incontinence | Avoid STARR; prefer VR, local rectocele repair; consider sacral neuromodulation when incontinence predominates and the structural component is minor | Preference for VR or local repairs mitigates the risk of continence deterioration and prevents iatrogenic anal sphincter injury |
| ODS with excessive perineal descent | Long-standing straining; perineal sagging or descent > 3 cm, often coexisting with rectocele or internal prolapse | Defecography or dynamic MRI: Perineal descent > 3 cm and pelvic floor laxity; Associated rectocele/intussusception may be present but does not fully explain outlet obstruction | Combined surgery: STARR with TPS or VR with TPS | Reinforces perineal body and prevents recurrence; emerging phenotype-guided strategy with improved long-term functional outcomes |
- Citation: Schiano di Visconte M, Sarnari S. Beyond stapled transanal rectal resection vs ventral rectopexy dichotomy: Toward a phenotype-guided surgical paradigm for obstructed defecation syndrome. World J Gastrointest Surg 2026; 18(2): 116100
- URL: https://www.wjgnet.com/1948-9366/full/v18/i2/116100.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.116100
